Abstract:Objective: Following a mild traumatic brain injury (mTBI), the most prevalent and profoundly debilitating occurrence is the emergence of an acute and persistent post-traumatic headache (PTH), for which there are presently no approved treatments. A crucial gap in knowledge exists regarding the consequences of an mTBI, which could serve as a foundation for the development of therapeutic approaches. The activation of trigeminal sensory nerve terminals that innervate the calvarial periosteum (CP)—a densely innervated tissue layer covering the calvarial skull—has been implicated in both migraines and PTHs. We have previously shown that trigeminal oxytocin receptors (OTRs) may provide a therapeutic target for PTHs. This study examined the expression of oxytocin receptors on trigeminal nerves innervating the periosteum and whether these receptors might serve as a therapeutic target for PTHs using a direct application of oxytocin to the periosteum in a rodent model of PTH. Methods: We used retrograde tracing and immunohistochemistry to determine if trigeminal ganglion (TG) neurons innervating the periosteum expressed OTRs and/or CGRPs. To model the impact of local inflammation that occurs following an mTBI, we applied chemical inflammatory mediators directly to the CP and assessed for changes in immediate-early gene expression as an indication of neuronal activation. We also determined whether mTBI would lead to expression changes to OTR levels. To determine whether these OTRs could be a viable therapeutic target, we assessed the impact of oxytocin injections into the CP in a mouse model of PTH-induced periorbital allodynia. Results: The results of these experiments demonstrate the following: (1) the cell bodies of CP afferents reside in the TG and express both OTRs and CGRPs; (2) inflammatory chemical stimulation of the periosteum leads to rapid activation of TG neurons (phospho-ERK (p-ERK) expression), (3) mTBI-induced inflammation increased OTR expression compared to the sham group; and (4) administration of oxytocin into the periosteum on day 2 and day 40 blocked cutaneous allodynia for up to one hour post-administration for both acute and persistence phases in the PTH model—an effect that was preventable by the administration of an OTR antagonist. Conclusion: Taken together, our observations suggest that periosteal trigeminal afferents contribute to post-TBI craniofacial pain, and that periosteum tissue can be used as a potential local target for therapeutics such as oxytocin.

Hypersensitivity to BKCa channel opening in persistent post-traumatic headache

Hypersensitivity to opening of ATP-sensitive potassium channels in post-traumatic headache

Biomarkers and Endophenotypes of Post-traumatic Headaches

Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling

Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial

CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury

Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial

Post-traumatic Headache: Pharmacologic Management and Targeting CGRP Signaling

Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial

Distinct expression profile reveals glia involvement in the trigeminal system attributing to post-traumatic headache

Oxytocin Receptors on Calvarial Periosteal Innervation: Therapeutic Target for Post-Traumatic Headache?

Functional Analysis of A Migraine-Associated Tresk K+ Channel Mutation

Altered hypothalamic functional connectivity in post-traumatic headache after mild traumatic brain injury

The role of deficient pain modulatory systems in the development of persistent post-traumatic headaches following mild traumatic brain injury: an exploratory longitudinal study

Protein kinase Cδ as a neuronal mechanism for headache in a chronic intermittent nitroglycerin model of migraine in mice

Posttraumatic headache is a distinct headache type from migraine

Narrative Review of the Pathophysiology of Headaches and Photosensitivity in Mild Traumatic Brain Injury and Concussion

Cutaneous heat and light‐induced pain thresholds in post‐traumatic headache attributed to mild traumatic brain injury

Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study

Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study

Vascular large conductance calcium-activated potassium channels: Functional role and therapeutic potential